Crossline-like Structure Accumulates as Fluorescent Advanced Glycation End Products in Renal Tissues of Rats with Diabetic Nephropathy

スポンサーリンク

概要

• 論文の詳細を見る

• Although formation of characteristic fluorescence (Exmax/Emmax:370/440nm) in renal tissues has been known to be enhanced in diabetic model rats and the natural fluorophores have been thought as advanced glycation end products (AGEs), these structures remain unclear to this date. Since we had already isolated Crossline derivatives as the main fluorescent AGE-products formed in a sugar-amine-model system in vitro, we tried to determine whether crossline-like structure can be found in renal tissues of rats with diabetic nephropathy. Specific polyclonal antiserum against crossline-structure and its affinity chromatography-purified antibody were prepared. The purified antibody did not recognize native rat serum albumin (RSA), but it recognized RSA modified by prolonged incubation with high concentration of glucose (AGE-RSA) as well as the crossline-hapten. The immunoreactivity of AGE-RSA was completely blocked by co-incubation with crossline-derivative. These results confirm immunochemically that in vitro-prepared AGE-proteins contain crossline-like structure. Similarly, crossline-like structure in AGE-proteins in vivo was examined immunohistochemically. In streptozotocin-induced diabetic rats, both crossline-like immunoreactivity and fluorescence (Ex/Em:370/440 nm) of renal tissues increased, and the levels rose further with progression of diabetic nephropathy. Crossline accumulation was observed in specific renal tissues such as glomeruli (basement membrane and mesangium), tubules, and Bowmans capsules. Although the contribution of crossline-like substance(s) to total fluoroescence in diabetic renal tissues has not as yet been quantitatively determined, our results provide evidence that crossline accumulation occurs in renal tissues of rats in association with the initiation and/or progression of diabetic nephropathy.

著者

• Nakamura Ko

  Institute Of Bio-active Science (ibas) Nippon Zoki Pharm. Co. Ltd

• Ienaga Kazuharu

  Institute Of Bio-active Science (ibas) Nippon Zoki Pharm. Co. Ltd

• NAKANO KOJI

  First Department of Internal Medicine, Kyoto Prefectural University

• HASEGAWA Goji

  First Internal Medicine, Kyoto Prefectural University of Medicine

• KAKITA Hideharu

  First Internal Medicine, Kyoto Prefectural University of Medicine

• HOCHI Toshikazu

  Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co. Ltd.

• NAKAZAWA Yoshitaka

  Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co. Ltd.

• FUKUNAGA Yasutsugu

  Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co. Ltd.

• AOKI Shin-ichiro

  First Internal Medicine, Kyoto Prefectural University of Medicine

• TSUTSUMI Yoshinobu

  First Internal Medicine, Kyoto Prefectural University of Medicine

• KITAGAWA Yoshihiro

  First Internal Medicine, Kyoto Prefectural University of Medicine

• IENAGA Kazuharu

  Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co. Ltd.

• NAKAMURA Ko

  Institute of Bio-Active Science, Nippon Zoki Pharmaceutical Co. Ltd.

関連論文

• A New Nonpeptide Tachykinin NK_1 Receptor Antagonist Isolated from the Plants of Compositae
• PD14 THE METABOLISM OF 1-METHYLHYDANTOIN IN MAMMALS
• Serum Concentrations of Δ5-3β-Hydroxysteroids in Type 2 Diabetes Mellitus
• Crossline-like Structure Accumulates as Fluorescent Advanced Glycation End Products in Renal Tissues of Rats with Diabetic Nephropathy
• Effect of Islet-Activating Protein (IAP) Upon Insulin Secretion from Human Pancreatic Islets
• The Insulin Secretion of a Minced Neonatal Rat Pancreas Cultured in a Pancreatic Chamber, in Response to Various Insulin Secretagogues
• Creatones A and B. Revision of the structure for the product of oxidation of creatinine and creatine.

スポンサーリンク